After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
The medical devices company is likely to stick to small- to mid- sized M&A unless it finds itself the target.
Look for ABT's declining trend to continue a while longer.
Doug Kass shares his thoughts on 'stuck' markets and on differing risk appetites and timeframes.
St. Jude shares deserve to be higher ahead of the merger with Abbott Labs. Here's why.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.